Research Article

A Pilot Study on Intravesical Administration of Curcumin for Cystitis Glandularis

Table 1

Characteristics of curcumin-treated patients.

PatientSexAge (years)SubtypeCLSSHematuria
Baseline4 weeks3 months6 monthsBaseline4 weeks3 months6 months

1M36CGTP10756GrossMicroMicroMicro
2M58CGIT10866GrossGross
3M43CGTP9755MicroMicroMicroMicro
4F64CGIT10101010MicroMicroMicroMicro
5M56CGTP13976
6F30CGTP13977MicroMicroMicroMicro
7F48CGTP10767MicroMicroMicroMicro
8M23CGIT12977MicroMicro
9M47CGIT10111010MicroMicroMicroMicro
10F42CGTP10756
11M72CGTP101010NDMicroMicroMicroND
12F18CGTP976NDND
13M52CGIT9999GrossGrossMicroMicro
14M32CGTP9666GrossMicroMicro

F: female; M: male; CGTP: typical CG; CGIT: intestinal CG; CLSS: core lower urinary tract symptom score; Micro: microscopic hematuria; Gross: gross hematuria; −: negative hematuria; ND: not determined due to loss to follow-up.